Pine Valley Investments’s AstraZeneca AZN Stock Holding History

Pine Valley Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Hold	2,426	–	–	0.02%	411
2026 Q1	$478K	Buy	+2,426	New	+$468K	0.02%	387
2025 Q4	–	Sell	-2,518	Closed	-$386K	–	567
2025 Q3	$386K	Hold	2,518	–	–	0.02%	397
2025 Q2	$352K	Sell	2,518 -100	-4%	-$14K	0.02%	396
2025 Q1	$385K	Sell	2,618 -380	-13%	-$55K	0.02%	373
2024 Q4	$393K	Buy	2,998 +95	+3%	+$13.3K	0.02%	375
2024 Q3	$452K	Buy	2,903 +1	+0%	+$161	0.03%	335
2024 Q2	$453K	Sell	2,902 -89	-3%	-$13.4K	0.03%	320
2024 Q1	$405K	Sell	2,991 -195	-6%	-$25.8K	0.03%	344
2023 Q4	$429K	Buy	3,186 +296	+10%	+$38.5K	0.03%	325
2023 Q3	$391K	Buy	2,890 +161	+6%	+$22K	0.04%	326
2023 Q2	$391K	Buy	+2,729	New	+$402K	0.04%	288

Other funds holding AZN

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pine Valley Investments's AZN Position: Q2 2026 in Review

Pine Valley Investments held its AstraZeneca (AZN) position steady in Q2 2026 at 2,426 shares worth $460K. The position accounts for 0.02% of the portfolio, ranked #411.

Pine Valley Investments first reported a position in AZN in Q2 2023 and has held it in 12 quarters since. The position peaked at $478K in Q1 2026. 802 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Pine Valley Investments held 2,426 shares of AstraZeneca worth $460K as of Q2 2026.
Pine Valley Investments left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.02% of Pine Valley Investments's portfolio in Q2 2026, its #411 holding.
Pine Valley Investments first reported a position in AstraZeneca in Q2 2023 and has held it in 12 quarters since.
Pine Valley Investments's AstraZeneca position peaked at $478K in Q1 2026.
802 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.